CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...